Clinical, Genetic, Biomarker Model IDs Risk for Pancreatic Cancer
WEDNESDAY, April 22, 2020 -- A model that includes data on clinical and genetic factors and circulating biomarkers may improve risk discrimination for pancreatic cancer, according to a study published online April 22 in Cancer Epidemiology,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Epidemiology | Genetics | Pancreas | Pancreatic Cancer | Pharmaceuticals | Study